bf/NYSE:ABBV_icon.jpeg

NYSE:ABBV

AbbVie Inc.

  • Stock

193.34

−0.90%

−5.30

USD last updated 11/08 02:03:55

Last Close

198.64

11/08 22:30

Market Cap

296.91B

Beta: 0.55

Volume Today

5.82M

Avg: 6.07M

PE Ratio

46.58

PFCF: 12.27

Dividend Yield

3.48%

Payout:159.95%

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients;...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    12342017-04-272019-04-252021-04-302023-04-272024-10-25

    Revenue (Estimate*)

    5B10B15B2017-04-272019-04-252021-04-302023-04-272024-10-25

    *Estimate based on analyst consensus